Answers are grounded in this paper and cite their sources.
Silaheterocycles, XXV[1]. — (Me3SiO)2SiCHCH2tBu: A Siloxy‐Functionalized Synthetic Equivalent for Dichloroneopentylsilene (Me3SiO)2SiCHCH2tBu (4) is obtained by the reaction of (Me3SiO)2Si(Cl)CHCH2 (2) with LitBu. The reaction proceeds via the α‐lithiated species 3, which can be intercepted by trimethylsilyl triflate to give 5. Silaethene 4 dimerizes to the E/Z‐isomers of disilacyclobutane 7 and adds to Me3SiOMe to give 6. The reactivity of 4 resembles that of Cl2SiCHCH2tBu (1): A [4 + 2] cycloadduct is obtained from the reaction with anthracene, and with 1,3‐cyclohexadiene and 1,3‐cycloheptadiene mixtures of monosilacyclobutanes (10 and 12) and bicyclic Diels‐Alder adducts (9 and 11) are available. Exclusive [2 + 2] cycloaddition reactions take place with styrene (formation of 13), 2,3‐dimethyl‐1,3‐butadiene (→19), and 1,3‐butadiene (→21). With quadricyclane only the product (14) originating from a [2 + 2 + 2] cycloaddition is formed, while with 2,5‐norbornadiene the [2 + 2] and [2 + 2 + 2] cycloadducts (14 and 15) are formed. In addition the ene products (16, 18, 20, 22) are isolated in some cases from side reactions. — The tendency of 1 and 4 to preferably participate in [2 + 2] cycloaddition reactions is ascribed to the polarity of the SiC bond and the additional influence of the π donor ligands at silicon. These factors enable a stepwise [2 + 2] reaction in which the primary zwitterionic intermediates B are cyclized to yield the SiC four‐membered ring compounds.
No takes yet. Share an insight, caveat, or question.
Auner et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: